Leonardina Ciccarelli
Overview
Explore the profile of Leonardina Ciccarelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Derosa G, Cicero A, Franzetti I, Querci F, Carbone A, Ciccarelli L, et al.
Can J Physiol Pharmacol
. 2013 Aug;
91(9):724-32.
PMID: 23984793
The aim of this study was to evaluate the effects of exenatide on levels of serum adipocytokines and on β-cell function. The study was conducted between 2008 and 2012. After...
2.
Derosa G, Franzetti I, Querci F, Carbone A, Ciccarelli L, Piccinni M, et al.
Pharmacotherapy
. 2013 Jun;
33(8):817-26.
PMID: 23744726
Study Objective: To evaluate the effects of exenatide on some inflammatory markers and to quantify the effect of exenatide on β-cell function. Design: A randomized, double-blind, placebo-controlled trial. Setting: Seven...
3.
4.
Derosa G, Maffioli P, Salvadeo S, Ferrari I, Ragonesi P, Querci F, et al.
Metabolism
. 2009 Dec;
59(6):887-95.
PMID: 20015525
The aim of the study was to compare the effects of the addition of sitagliptin or metformin to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients on body...
5.
Derosa G, Salvadeo S, Mereu R, DAngelo A, Ciccarelli L, Piccinni M, et al.
Diabetes Technol Ther
. 2009 Mar;
11(3):159-69.
PMID: 19267581
Background And Aim: The Continuous Glucose Monitoring System (CGMS) (Medtronic Minimed, Northridge, CA) provides an opportunity to better understand abnormalities in glucose metabolism in both healthy subjects and those with...
6.
Derosa G, Mereu R, Salvadeo S, DAngelo A, Ciccarelli L, Piccinni M, et al.
Intern Med
. 2009 Mar;
48(5):265-71.
PMID: 19252346
Objective: Metformin is the drug of choice to treat obese type 2 diabetes patients because it reduces either insulin-resistance and body weight. We aimed to comparatively test the efficacy and...
7.
Derosa G, Salvadeo S, DAngelo A, Fogari E, Ragonesi P, Ciccarelli L, et al.
Arch Med Res
. 2008 Apr;
39(4):412-9.
PMID: 18375253
Background: Few studies have directly compared rosiglitazone and metformin effects on adipocytokines. The aim was to observe the possible effects of rosiglitazone and metformin on glycemic control, insulin sensitivity, plasma...
8.
Derosa G, Fogari E, Cicero A, DAngelo A, Ciccarelli L, Piccinni M, et al.
Hypertens Res
. 2007 Jun;
30(5):387-94.
PMID: 17587750
The aim of the study was to assess the effects of the combination of metformin plus pioglitazone or rosiglitazone on glucose and blood pressure in type 2 diabetic patients with...
9.
Derosa G, Cicero A, DAngelo A, Ragonesi P, Ciccarelli L, Piccinni M, et al.
Hypertens Res
. 2007 Mar;
29(11):849-56.
PMID: 17345784
The aim of our study was to investigate the metabolic effect of telmisartan and irbesartan in subjects treated with rosiglitazone, a well-known insulin-sensitizing drug, in order to clarify the direct...
10.
Derosa G, Cicero A, DAngelo A, Ragonesi P, Ciccarelli L, Fogari E, et al.
Clin Drug Investig
. 2006 Dec;
26(9):529-39.
PMID: 17163286
Objective: The aim of this study was to evaluate if the expected improvement in glucose and lipid metabolism obtainable with doxazosin is or is not synergistic with standard antihyperglycaemic treatment...